Search

Your search keyword '"Robins H"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Robins H" Remove constraint Author: "Robins H" Journal journal of clinical oncology Remove constraint Journal: journal of clinical oncology
27 results on '"Robins H"'

Search Results

1. Phase II Trial of Tipifarnib in Patients With Recurrent Malignant Glioma Either Receiving or Not Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study

2. Phase I Trial of Tipifarnib in Patients With Recurrent Malignant Glioma Taking Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study

3. Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis

4. Polymorphisms risk modeling for vascular toxicity in patients with glioblastoma treated on NRG Oncology/RTOG 0825.

5. Results of NRG oncology/RTOG 9813: A phase III randomized study of radiation therapy (RT) and temozolomide (TMZ) versus RT and nitrosourea (NU) therapy for anaplastic astrocytoma (AA).

6. Comparative impact of treatment on patient reported outcomes (PROs) in patients with glioblastoma (GBM) enrolled in RTOG 0825.

7. Neurocognitive function (NCF) outcomes in patients with glioblastoma (GBM) enrolled in RTOG 0825.

8. Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study

9. Phase I study of vorinostat in combination with temozolomide in patients with malignant gliomas.

18. Prospective neurocognitive effects and quality of life (QOL) in patients with multiple brain metastases receiving whole brain radiation (WBRT) ± thalidomide on radiation therapy oncology group (RTOG) trial 0118

22. Phase I Trial of Intravenous Thymidine and Carboplatin in Patients With Advanced Cancer

23. Phase II Study of Phenylacetate in Patients With Recurrent Malignant Glioma: A North American Brain Tumor Consortium Report

24. Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.

25. Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients.

Catalog

Books, media, physical & digital resources